Mouse Anti-FDX1 Recombinant Antibody (CBXF-0486) (V2LY-0925-LY1162)

Li, X., Dai, Z., Liu, J., Sun, Z., Li, N., Jiao, G., & Cao, H. (2022). Characterization of the functional effects of ferredoxin 1 as a cuproptosis biomarker in cancer. Frontiers in Genetics, 13.

Yang, L., Zhang, Y., Wang, Y., Jiang, P., Liu, F., & Feng, N. (2022). Ferredoxin 1 is a cuproptosis-key gene responsible for tumor immunity and drug sensitivity: A pan-cancer analysis. Frontiers in Pharmacology, 13.

Schulz, V., Basu, S., Freibert, S. A., Webert, H., Boss, L., Mühlenhoff, U., ... & Lill, R. (2022). Functional spectrum and specificity of mitochondrial ferredoxins FDX1 and FDX2. Nature Chemical Biology, 1-12.

Zhang, W. T., Gong, Y. M., Zhang, C. Y., Pan, J. S., Huang, T., & Li, Y. X. (2022). A Novel Cuprotosis-Related Gene FDX1 Signature for Overall Survival Prediction in Clear Cell Renal Cell Carcinoma Patients. BioMed Research International, 2022.

Huang, X., Wang, T., Ye, J., Feng, H., Zhang, X., Ma, X., ... & Zhang, X. (2022). FDX1 expression predicts favourable prognosis in clear cell renal cell carcinoma identified by bioinformatics and tissue microarray analysis. Frontiers in Genetics, 13, 994741.

Tsvetkov, P., Detappe, A., Cai, K., Keys, H. R., Brune, Z., Ying, W., ... & Lindquist, S. (2018). Inhibition of mitochondrial ferredoxin 1 (FDX1) prevents adaptation to proteotoxic stress. bioRxiv, 288365.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols